Quantcast

Latest diabetic neuropathy Stories

2009-03-20 07:00:00

Qutenza(TM) Receives Positive Committee Recommendation in European Union Corporate Highlights: - CHMP issued positive opinion recommending approval of Qutenza(TM) (formerly NGX-4010) for treatment of peripheral neuropathic pain in non-diabetic adults either alone or in combination with other medicinal products for pain - Qutenza NDA accepted for review by U.S.

2009-03-19 15:24:00

Broad Label Indicated for Peripheral Neuropathic Pain in Non-Diabetic Adults Conference Call Scheduled Friday, March 20 at 9am ET SAN MATEO, Calif., March 19 /PRNewswire-FirstCall/ -- NeurogesX, Inc.

2009-02-05 10:04:33

Transplanting cells that replenish blood vessels can also restore nerve function in an animal model of diabetic neuropathy, Emory researchers have found.

2009-01-14 06:55:29

More than 20 million Americans are living with diabetes, and that number is expected to increase by more than 5 million by 2010.

2008-12-08 08:29:42

It’s now easier to know who should be tested for a common nerve disorder, when they should be tested, and how.

2008-11-12 09:00:10

DOYLESTOWN, Pa., Nov. 12 /PRNewswire-FirstCall/ -- Quigley Pharma Inc., a wholly-owned subsidiary of The Quigley Corporation announced today that the last subject in the Phase IIb Study is scheduled to complete treatment on November 25, 2008.

2008-11-11 09:00:47

Sangamo BioSciences, a developer of novel DNA-binding proteins for therapeutic gene regulation and modification, has announced top-line data from its SB-509-601 clinical trial, one of Sangamo's three Phase II clinical studies from its ZFP therapeutic program to develop SB-509 for diabetic neuropathy.

2008-11-10 18:00:05

RICHMOND, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. announced today top-line data from its SB-509-601 clinical trial, one of Sangamo's three Phase 2 clinical studies from its ZFP Therapeutic(TM) program to develop SB-509 for diabetic neuropathy (DN).

2008-10-08 09:00:12

XTL Biopharmaceuticals, a developer of therapeutics for the treatment of diabetic neuropathic pain and hepatitis C virus, has announced that the last patient randomized into the Bicifadine Phase IIb clinical trial for the treatment of diabetic neuropathic pain has completed the study.

2008-09-15 12:00:35

RICHMOND, Calif., Sept. 15 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.


Word of the Day
gazingstock
  • A person or thing gazed at with wonder or curiosity, especially of a scornful kind.
The 'stock' of 'gazingstock' comes from an Old English word meaning 'tree trunk' or 'wood'.
Related